A new kind of endoscope developed at the University of East Anglia (UEA) could aid in the early detection of inflammatory bowel disease.
Working alongside an international team of researchers, UEA has developed a system that involves a minitaurised microscope attached to the tip of a conventional colonoscope for use during routine colonoscopy.
Known as the Confocal Laser Endomicroscope (CLE), the tool allows clinicians to image the bacteria that are thought to trigger diseases of the bowel such as Crohn’s disease and ulcerative colitis.
Previously, viewing bacteria within the wall of the gut was problematic because biopsies would disrupt the structure of the mucosal architecture, preventing observation of the bacteria’s exact location and the way it interacts with its surrounding environment.
The CLE, however, uses a contrast agent within the gut mucosa, removing the need to cut into tissue. Instead a dye is injected into a patient’s vein to highlight the bacteria and allow it to be viewed at a sub-cellular level using the CLE.
The process is thought to detect bacteria with a sensitivity of 89 per cent. Prof Alastair Watson, who led the work at UEA, now wants to take the technique into larger patient groups for testing.
‘There was no practical way to do this before, previous methods where cumbersome and time consuming,’ he said. ‘This is opening up a new area. I think it’s quite exciting to diagnose disease at earlier stages and try and get patients treatment before it gets too serious.’
It is not yet fully understood what causes Crohn’s disease and ulcerative colitis. Of the 163 people studied as part of UEA’s research, it was found that patients with these diseases were much more likely to have bacteria within the wall of their gut than those with healthy intestines.